KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Current Leases: 2021-2025

Historic Current Leases for Castle Biosciences (CSTL) over the last 4 years, with Sep 2025 value amounting to $1.4 million.

  • Castle Biosciences' Current Leases fell 16.96% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 16.96%. This contributed to the annual value of $1.7 million for FY2024, which is 46.44% up from last year.
  • As of Q3 2025, Castle Biosciences' Current Leases stood at $1.4 million, which was down 7.77% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Current Leases registered a high of $2.0 million during Q2 2023, and its lowest value of $1.1 million during Q3 2023.
  • Over the past 3 years, Castle Biosciences' median Current Leases value was $1.4 million (recorded in 2025), while the average stood at $1.5 million.
  • In the last 5 years, Castle Biosciences' Current Leases spiked by 62.35% in 2023 and then slumped by 37.64% in 2024.
  • Over the past 5 years, Castle Biosciences' Current Leases (Quarterly) stood at $1.2 million in 2021, then soared by 50.72% to $1.8 million in 2022, then plummeted by 36.02% to $1.1 million in 2023, then skyrocketed by 46.44% to $1.7 million in 2024, then fell by 16.96% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.6 million for Q2 2025, and $1.4 million during Q1 2025.